Cardiology
News
Andexanet alfa effectively reverses factor Xa inhibition
HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated...
News
Higher blood pressure after thrombectomy links with bad stroke outcomes
HONOLULU – Observational data showed that ischemic stroke patients with systolic blood pressure above 158 mm Hg after thrombectomy had worse...
News
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
News
Five pitfalls in optimizing medical management of HFrEF
SNOWMASS, COLO. – “A key message is that stability is an illusion in patients with symptomatic heart failure.” – Dr. Akshay S. Desai
News
Glyceryl trinitrate does not improve outcomes of ischemic stroke
HONOLULU – Although treatment reduced blood pressure, it did not reduce disability at 90 days, compared with sham....
News
Infective endocarditis isn’t what it used to be
News
New SOFA version could streamline outcomes research
The eSOFA includes more objective criteria and should make it easier to compare data across institutions.
News
ICU admissions raise chronic condition risk
Compared to non-ICU visitors, patients had greater risk of developing new chronic conditions after discharge.
News
Deferoxamine does not improve 90-day outcomes after ICH
HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.
News
SGLT2 inhibitors morph into HF drugs
“